
Insulet Corporation PODD
$ 225.5
-0.7%
Quarterly report 2025-Q3
added 03-14-2026
Insulet Corporation Operating Cash Flow 2011-2026 | PODD
Annual Operating Cash Flow Insulet Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 569 M | 430 M | 146 M | 119 M | -68.1 M | 84 M | 98.4 M | 35.9 M | 41.3 M | 15.9 M | -12.6 M | 8.92 M | 3.35 M | -29.1 M | -25.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 569 M | -68.1 M | 94.5 M |
Quarterly Operating Cash Flow Insulet Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 63.8 M | - | - | - | 87.6 M | - | - | - | 500 K | - | - | - | -13.7 M | - | - | - | -35.1 M | - | 67 M | 22.8 M | -3.6 M | - | 51.5 M | 20.4 M | 6.5 M | - | 5.46 M | -10.4 M | -4.27 M | - | 19.4 M | -3.87 M | -21.8 M | - | -4.16 M | -6.84 M | -10.5 M | - | 6.04 M | -2.7 M | -3.49 M | - | 4.31 M | -509 K | -1.02 M | - | 6.87 M | 3.17 M | -1.2 M | - | -23.5 M | -20 M | -8.9 M | - | -17.8 M | -16.9 M | -7.87 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 87.6 M | -35.1 M | 4.21 M |
Operating Cash Flow of other stocks in the Medical devices industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
45.2 M | $ 11.75 | -3.29 % | $ 1.76 B | ||
|
BioSig Technologies
BSGM
|
-4.76 M | - | 37.08 % | $ 85.7 M | ||
|
Axonics Modulation Technologies
AXNX
|
3.19 M | - | - | $ 3.31 B | ||
|
Delcath Systems
DCTH
|
22.5 M | $ 8.98 | -1.32 % | $ 322 M | ||
|
Aziyo Biologics
AZYO
|
-44.8 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
-63.1 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
-4.1 M | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
-20.8 M | - | -0.97 % | $ 54.4 M | ||
|
FONAR Corporation
FONR
|
15.3 M | $ 18.41 | 0.38 % | $ 121 M | ||
|
Conformis
CFMS
|
-50.2 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
-24.3 M | - | 0.15 % | $ 844 M | ||
|
Inogen
INGN
|
-11.2 M | $ 6.32 | -2.02 % | $ 168 M | ||
|
Apollo Endosurgery
APEN
|
-31.3 M | - | - | $ 475 M | ||
|
IRIDEX Corporation
IRIX
|
-6.74 M | $ 1.35 | - | $ 21.8 M | ||
|
IRadimed Corporation
IRMD
|
24.9 M | $ 100.97 | 1.78 % | $ 1.28 B | ||
|
Avinger
AVGR
|
-14.4 M | - | -20.74 % | $ 369 K | ||
|
LivaNova PLC
LIVN
|
254 M | $ 62.4 | -1.33 % | $ 3.4 B | ||
|
LENSAR
LNSR
|
-2.28 M | $ 5.56 | -8.4 % | $ 64 M | ||
|
AxoGen
AXGN
|
812 K | $ 32.61 | 2.71 % | $ 1.5 B | ||
|
CONMED Corporation
CNMD
|
171 M | $ 36.56 | -0.19 % | $ 1.13 B | ||
|
Medtronic PLC
MDT
|
7.04 B | $ 86.58 | -0.68 % | $ 111 B | ||
|
NanoVibronix
NAOV
|
-2.52 M | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
11.4 M | $ 24.7 | 0.86 % | $ 209 M | ||
|
Neovasc
NVCN
|
-27.1 M | - | - | $ 111 M | ||
|
InspireMD
NSPR
|
-35.1 M | $ 1.79 | 3.47 % | $ 115 M | ||
|
Orthofix Medical
OFIX
|
33.3 M | $ 11.72 | -1.26 % | $ 464 M | ||
|
Cytosorbents Corporation
CTSO
|
-14.4 M | $ 0.7 | 3.3 % | $ 38.1 M | ||
|
Aethlon Medical
AEMD
|
-7.65 M | $ 2.16 | -6.09 % | $ 3.37 M | ||
|
Profound Medical Corp.
PROF
|
-22.4 M | $ 5.15 | -4.63 % | $ 180 M | ||
|
BIOLASE
BIOL
|
-14.1 M | - | -13.19 % | $ 166 K | ||
|
Penumbra
PEN
|
239 M | $ 334.17 | -0.41 % | $ 13 B | ||
|
AdaptHealth Corp.
AHCO
|
602 M | $ 11.48 | 10.7 % | $ 1.55 B | ||
|
Myomo
MYO
|
-14.5 M | $ 0.7 | -1.83 % | $ 29.3 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
-36.6 M | $ 2.4 | -1.64 % | $ 141 M | ||
|
Invacare Corporation
IVC
|
-55.3 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
-13.6 M | $ 3.91 | 4.83 % | $ 146 M | ||
|
Quanterix Corporation
QTRX
|
-77.2 M | $ 3.82 | -3.05 % | $ 163 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-4.85 M | $ 15.91 | -3.4 % | $ 373 M | ||
|
Outset Medical
OM
|
-46.3 M | $ 3.53 | -2.35 % | $ 53.7 K |